nonprofit logo

The American Society Of Gene & Cell Therapy

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 911766321 ✦ Waukesha, WI ✦ Designated as a 501(c)(3)

Overview

What is The American Society Of Gene & Cell Therapy?

The American Society of Gene & Cell Therapy, based in Waukesha, Wisconsin, is a dynamic nonprofit organization with a mission to expand knowledge, spark awareness, and foster education in the field of genetic and cellular therapies to combat human diseases. Their primary means of achieving this goal is through their annual meeting, which acts as the cornerstone of their educational mission. With a dedicated team of approximately 40 employees, the society is committed to advancing the discovery and clinical application of these therapies.


Official website here: www.asgct.org

Is The American Society Of Gene & Cell Therapy legitimate?

The American Society Of Gene & Cell Therapy is a legitimate nonprofit organization registered as a 501(c)(3) entity. The American Society Of Gene & Cell Therapy submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $361,175
Professional Fundraising Fees: $0
Other Salaries and Wages: $2,521,869

For more financial information, click here


Official website here: www.asgct.org

What is the mission statement of The American Society Of Gene & Cell Therapy?

The American Society of Gene & Cell Therapy (ASGCT) is dedicated to advancing knowledge, awareness, and education in the field of genetic and cellular therapies to alleviate human diseases. This mission is carried out primarily through the Annual Meeting, which serves as the major educational initiative of the society. ASGCT aims to disseminate information and foster collaboration among researchers, clinicians, and industry professionals to drive discoveries in this rapidly evolving field. The organization's ultimate goal is to translate scientific breakthroughs into clinical applications, ultimately improving the lives of those afflicted by various diseases.


Official website here: www.asgct.org

Who is the CEO of The American Society Of Gene & Cell Therapy?

Paloma H Giangrande Phd is the President of The American Society Of Gene & Cell Therapy.


Official website here: www.asgct.org

What is the revenue of The American Society Of Gene & Cell Therapy?

The American Society Of Gene & Cell Therapy's revenue in 2022 was $12,483,052.


Official website here: www.asgct.org

Who are the executives of The American Society Of Gene & Cell Therapy and what are their salaries?

The average compensation at The American Society Of Gene & Cell Therapy during 2022 was $72,076. There are 40 employees and 15 volunteers at The American Society Of Gene & Cell Therapy.

Here are 21 key members and their salaries:

    David Barrett (Executive Director)
  • Compensation: $325,069
  • Related: $0
  • Other: $36,107

    • Margarita Lea Valdez (Employee)
  • Compensation: $148,375
  • Related: $0
  • Other: $4,451

    • Laura Michelle Gallagher (Employee)
  • Compensation: $130,674
  • Related: $0
  • Other: $12,363

    • Grant Holley (Employee)
  • Compensation: $130,686
  • Related: $0
  • Other: $10,998

    • Courtney Michelle Bricker-Anthony (Employee)
  • Compensation: $105,207
  • Related: $0
  • Other: $25,233

    • Alex Wendland (Employee)
  • Compensation: $112,167
  • Related: $0
  • Other: $3,365

    • Beverly Davidson Phd (President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Hans-Peter Kiem Md Phd (President Elect) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Stephen J Russell Md Phd (Past President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jeffrey S Chamberlain Phd (Vice President) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Terence R Flotte Md (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paloma H Giangrande Phd (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Anastasia Khvorova Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Federico Mingozzi Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Hildegard Buning Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Marcela V Maus Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Maria-Grazia Roncarolo Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Maritza Mcintyre Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Matthew Wilson Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Philip Gregory Dphil (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Rayne H Rouce Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.asgct.org

    Where can I find the form 990 for The American Society Of Gene & Cell Therapy?

    The The American Society Of Gene & Cell Therapy’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.asgct.org

    Learn more at the official website: www.asgct.org

    Mission Statement of The American Society Of Gene & Cell Therapy

    The American Society of Gene & Cell Therapy (ASGCT) is an influential organization dedicated to advancing knowledge, awareness, and education in the field of genetic and cellular therapies. With a mission to discover and clinically apply these therapies to alleviate human disease, ASGCT plays a pivotal role in driving innovation and progress in healthcare.

    ASGCT's primary focus lies in promoting knowledge and education, acting as a hub for the latest research and developments in gene and cell therapies. One of the most significant ways the society achieves this is through its annual meeting. This event is a focal point for ASGCT's educational mission, bringing together industry experts, researchers, and professionals to share their findings, discuss advancements, and explore new possibilities. The annual meeting serves as a platform to inspire and fuel the collective passion for uncovering new ways to harness the power of gene and cell therapies to improve human health.

    In addition to the annual meeting, ASGCT fosters awareness and education through various initiatives. By fostering collaboration among its members and the wider scientific community, the organization creates opportunities for the exchange of ideas, best practices, and innovations. Through its educational programs, ASGCT supports the development of the next generation of scientists and professionals in the field, ensuring a continuous flow of fresh perspectives and groundbreaking discoveries. In this way, ASGCT remains at the forefront of the genetic and cellular therapy landscape, driving progress and offering hope to those affected by various diseases.

    Impact

    This information is meant to be a general summary of The American Society Of Gene & Cell Therapy. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The American Society of Gene & Cell Therapy plays a crucial role in advancing knowledge, awareness, and education in the field of genetic and cellular therapies. Through its annual meeting, the society provides a platform for researchers, scientists, and clinicians to collaborate and share their cutting-edge research and discoveries. By facilitating these exchanges, ASGCT contributes to the progress of medical research and the development of novel treatments for human diseases.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $121,557
  • Program Service Revenue: $11,558,366
  • Gross Receipts: $12,483,052

    • Assets and Liabilities:
  • Total Assets: $20,486,557
  • Total Liabilities: $6,268,459
  • Net Assets: $14,218,098
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    REGISTRATIONS

    Revenue

    $6,828,709

    JOURNAL INCOME

    Revenue

    $2,163,164

    EXHIBIT REVENUE

    Revenue

    $1,493,751

    MEMBERSHIP DUES AND ASSESSMENTS

    Revenue

    $1,051,892

    ASGCT/ISSCR EVENT

    Revenue

    $20,850

    Organization Details

    Founding Year

    1996

    Principal Officer

    Paloma H Giangrande Phd

    Main Address

    20800 SWENSON DR 300, WAUKESHA, WI, 53186

    NTEE Category

    Code: H20 - Medical research

    If you are a representative of The American Society Of Gene & Cell Therapy and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.